ALLGENESIS

Serial Number 87741560
Registration 5707152
700

Registration Progress

Application Filed
Jan 3, 2018
Under Examination
Dec 18, 2018
Approved for Publication
Oct 23, 2018
Published for Opposition
Oct 23, 2018
Registered
Mar 26, 2019

Attorney Assistance

Important Deadline Approaching
Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-26)
Due: March 26, 2025 103 days overdue
Grace period ends: September 26, 2025

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
87741560
Registration Number
5707152
Filing Date
January 3, 2018
Registration Date
March 26, 2019
Published for Opposition
October 23, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 26, 2019
Registration
Registered
Classes
005

Rights Holder

Allgenesis Biotherapeutics Inc.

03
Address
7F.-1, No. 760, Sec. 4, Bade Rd.
Songshan Dist., Taipei 105
TW

Ownership History

Allgenesis Biotherapeutics Inc.

Original Applicant
03
Songshan Dist., Taipei TW

Allgenesis Biotherapeutics Inc.

Owner at Publication
03
Songshan Dist., Taipei TW

Allgenesis Biotherapeutics Inc.

Original Registrant
03
Songshan Dist., Taipei TW

Legal Representation

Attorney
Andrew Auderieth

USPTO Deadlines

Next Renewal Deadline
1358 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-03-26)
Due Date
March 26, 2029
Grace Period Ends
September 26, 2029

Application History

30 events
Date Code Type Description
Apr 14, 2025 PRA8 O POST REGISTRATION ACTION MAILED - SEC. 8
Apr 10, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 27, 2024 ES8R I TEAS SECTION 8 RECEIVED
Mar 26, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 26, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 15, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 15, 2019 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION
Feb 6, 2019 IUCN S NOTICE OF ALLOWANCE CANCELLED
Feb 6, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 15, 2019 D1BR I TEAS DELETE 1(B) BASIS RECEIVED
Dec 18, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 23, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 23, 2018 PUBO A PUBLISHED FOR OPPOSITION
Oct 3, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 17, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 17, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2018 ALIE A ASSIGNED TO LIE
Sep 6, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 12, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 3, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 20, 2018 UNDC O UNDELIVERABLE MAIL - COURTESY COPY MAILED
Apr 19, 2018 GNRT F NON-FINAL ACTION E-MAILED
Apr 19, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 19, 2018 CNRT R NON-FINAL ACTION WRITTEN
Apr 12, 2018 DOCK D ASSIGNED TO EXAMINER
Jan 17, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Medicines for the treatment of ophthalmic and central nervous system (CNS) diseases for human purposes; Diagnostic test reagents for medical purposes

Classification

International Classes
005